Overproduction of human M3 muscarinic acetylcholine receptor: An approach toward structural studies

Biotechnology Progress

Volumn 27, Issue 3, 2011, Pages 838-845

  Romero Fernandez, Wilber ^a   Garriga, Pere ^a   Borroto Escuela, Dasiel O ^a,b  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Codon optimization; Epitope tags; G protein coupled receptors; Muscarinic receptor; Overexpression; Semliki Forest virus

Indexed keywords

CODON OPTIMIZATION; EPITOPE TAGS; G PROTEIN COUPLED RECEPTORS; MUSCARINIC RECEPTOR; OVER-EXPRESSION; SEMLIKI FOREST VIRUS;

GENES; MAMMALS; NEURODEGENERATIVE DISEASES; OPTIMIZATION; STRUCTURAL ANALYSIS; VIRUSES;

ANTIGENS;

MUSCARINIC M3 RECEPTOR; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; MOLECULAR PROBE; TECHNIQUE; TUMOR GENE; UPREGULATION;

GENE EXPRESSION; GENES, NEOPLASM; HUMANS; METHODS; MOLECULAR PROBES; NEOPLASM PROTEINS; RECEPTOR, MUSCARINIC M3; TRANSFECTION; UP-REGULATION;

MAMMALIA; SEMLIKI FOREST VIRUS;

EID: 79958256657     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.615     Document Type: Article

References (37)

1. Eglen RM. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol. 2006; 26: 219-233.
2. Ishii M, Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des. 2006; 12: 3573-3581.
3. Khattar SK, Bora RS, Priyadarsiny P, Gupta D, Khanna A, Narayanan KL, Babu V, Chugh A, Saini KS. High level stable expression of pharmacologically active human M1-M5 muscarinic receptor subtypes in mammalian cells. Biotechnol Lett. 2006; 28: 121-129.
4. Ma P, Zemmel R. Value of novelty? Nat Rev Drug Discov. 2002; 1: 571-572.
5. Klabunde T, Hessler G. Drug design strategies for targeting G-protein-coupled receptors. Chembiochem. 2002; 3: 928-944.
6. Tate CG, Grisshammer R. Heterologous expression of G-protein-coupled receptors. Trends Biotechnol. 1996; 14: 426-430.
7. Minic J, Sautel M, Salesse R, Pajot-Augy E. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors. Curr Med Chem. 2005; 12: 961-969.
8. Schiller H, Haase W, Molsberger E, Janssen P, Michel H, Reilander H. The human ET(B) endothelin receptor heterologously produced in the methylotrophic yeast Pichia pastoris shows high-affinity binding and induction of stacked membranes. Recept Channel. 2000; 7: 93-107.
9. Aloia AL, Glatz RV, McMurchie EJ, Leifert WR. GPCR expression using baculovirus-infected Sf9 cells. Methods Mol Biol. 2009; 552: 115-129.
10. Sarramegna V, Talmont F, Demange P, Milon A. Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell Mol Life Sci. 2003; 60: 1529-1546.
11. Massotte D. G protein-coupled receptor overexpression with the baculovirus-insect cell system: a tool for structural and functional studies. Biochim Biophys Acta. 2003; 1610: 77-89.
12. Hassaine G, Wagner R, Kempf J, Cherouati N, Hassaine N, Prual C, André N, Reinhart C, Pattus F, Lundstrom K. Semliki Forest virus vectors for overexpression of 101 G protein-coupled receptors in mammalian host cells. Protein Expr Purif. 2006; 45: 343-351.
13. Chelikani P, Reeves PJ, Rajbhandary UL, Khorana HG. The synthesis and high-level expression of a beta2-adrenergic receptor gene in a tetracycline-inducible stable mammalian cell line. Protein Sci. 2006; 15: 1433-1440.
14. Mirzabekov T, Bannert N, Farzan M, Hofmann W, Kolchinsky P, Wu L, Wyatt R, Sodroski J. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J Biol Chem. 1999; 274: 28745-28750.
15. Babcock GJ, Mirzabekov T, Wojtowicz W, Sodroski J. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J Biol Chem. 2001; 276: 38433-38440.
16. Kukkonen JP, Nasman J, Ojala P, Oker-Blom C, Akerman KE. Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system. J Pharmacol Exp Ther. 1996; 279: 593-601.
17. Borroto Escuela DO, Perez Alea M, Fernandez WR, Gil DB. Vectors and P64k gene targeting for tandem affinity purification in Neisseria meningitidis. J Microbiol Methods. 2006; 65: 187-193.
18. Borroto-Escuela DO, Correia PA, Perez Alea M, Narvaez M, Garriga P, Fuxe K, Ciruela F. Impaired M(3) muscarinic acetylcholine receptor signal transduction through blockade of binding of multiple proteins to its third intracellular loop. Cell Physiol Biochem. 2010; 25: 397-408.
19. Borroto-Escuela DO, Garcia-Negredo G, Garriga P, Fuxe K, Ciruela F. The M(5) muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization. Biochim Biophys Acta. 2010; 1803: 813-825.
20. Van Craenenbroeck K, Gellynck E, Lintermans B, Leysen JE, Van Tol HH, Haegeman G, Vanhoenacker P. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor. Life Sci. 2006; 80: 74-81.
21. Han SJ, Hamdan FF, Kim SK, Jacobson KA, Brichta L, Bloodworth LM, Li JH, Wess J. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor. J Biol Chem. 2005; 280: 24870-24879.
22. Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta. 2003; 1610: 90-96.
23. Lundstrom K, Schweitzer C, Rotmann D, Hermann D, Schneider EM, Ehrengruber MU. Semliki Forest virus vectors: efficient vehicles for in vitro and in vivo gene delivery. FEBS Lett. 2001; 504: 99-103.
24. Mailman RB. GPCR functional selectivity has therapeutic impact. Trends Pharmacol Sci. 2007; 28: 390-396.
25. Kobilka B, Schertler GF. New G-protein-coupled receptor crystal structures: insights and limitations. Trends Pharmacol Sci. 2008; 29: 79-83.
26. Bradel-Tretheway BG, Zhen Z, Dewhurst S. Effects of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame. J Virol Methods. 2003; 111: 145-156.
27. Parker EM, Kameyama K, Higashijima T, Ross EM. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem. 1991; 266: 519-527.
28. Pickering BM, Willis AE. The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol. 2005; 16: 39-47.
29. Huang D, Gore PR, Shusta EV. Increasing yeast secretion of heterologous proteins by regulating expression rates and post-secretory loss. Biotechnol Bioeng. 2008; 101: 1264-1275.
30. Leskela TT, Markkanen PM, Pietila EM, Tuusa JT, Petaja-Repo UE. Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J Biol Chem. 2007; 282: 23171-23183.
31. Archer S, Meng S, Wu J, Johnson J, Tang R, Hodin R. Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery. 1998; 124: 248-253.
32. Ng GY, George SR, Zastawny RL, Caron M, Bouvier M, Dennis M, O'Dowd BF. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry. 1993; 32: 11727-11733.
33. Robeva AS, Woodard R, Luthin DR, Taylor HE, Linden J. Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure. Biochem Pharmacol. 1996; 51: 545-555.
34. Park PS, Wells JW. Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells. Biochemistry. 2003; 42: 12960-12971.
35. Hayashi MK, Haga T. Purification and functional reconstitution with GTP-binding regulatory proteins of hexahistidine-tagged muscarinic acetylcholine receptors (m2 subtype). J Biochem. 1996; 120: 1232-1238.
36. Zeng FY, Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem. 1999; 274: 19487-19497.
37. Hoffmann M, Verzijl D, Lundstrom K, Simmen U, Alewijnse AE, Timmerman H, Leurs R. Recombinant Semliki Forest virus for over-expression and pharmacological characterization of the histamine H(2) receptor in mammalian cells. Eur J Pharmacol. 2001; 427: 105-114.